Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rothman

Showing results (351-360 of 532) with videos related to

Pageof 54
Sort By:
Peptides|January 1, 1993
Phenylpiperidine opioid antagonists that promote weight loss in rats have high affinity for the kappa 2B (enkephalin-sensitive) binding siteR B Rothman, H Xu, G U Char, et al.
Brain Research. Developmental Brain Research|February 1, 1989
Cross-linking of [125I]beta-endorphin to mu-opioid receptors during developmentS McLean, R B Rothman, D M Chuang, et al.
Journal of Substance Abuse Treatment|April 1, 2000
An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependenceR B Rothman, D A Gorelick, S J Heishman, et al.
Synapse (New York, N.Y.)|March 14, 2002
Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout miceRichard B Rothman, F Ivy Carroll, Marisela Morales, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2014
Alpha-ethyltryptamines as dual dopamine-serotonin releasersBruce E Blough, Antonio Landavazo, John S Partilla, et al.
Journal of Medicinal Chemistry|September 29, 2012
14-Alkoxy- and 14-acyloxypyridomorphinans: μ agonist/δ antagonist opioid analgesics with diminished tolerance and dependence side effectsSubramaniam Ananthan, Surendra K Saini, Christina M Dersch, et al.
Peptides|November 1, 1992
Probing the opioid receptor complex with (+)-trans-SUPERFIT. II. Evidence that mu ligands are noncompetitive inhibitors of the delta cx opioid peptide binding siteR B Rothman, A Mahboubi, V Bykov, et al.
Journal of Medicinal Chemistry|January 21, 2011
Probes for narcotic receptor mediated phenomena. 41. Unusual inverse μ-agonists and potent μ-opioid antagonists by modification of the N-substituent in enantiomeric 5-(3-hydroxyphenyl)morphansKejun Cheng, Yong Sok Lee, Richard B Rothman, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2009
Design, synthesis, and characterization of 6beta-naltrexol analogs, and their selectivity for in vitro opioid receptor subtypesAndrea L Pelotte, Ryan M Smith, Mario Ayestas, et al.
Journal of Medicinal Chemistry|July 25, 2009
Probes for narcotic receptor mediated phenomena. 39. Enantiomeric N-substituted benzofuro[2,3-c]pyridin-6-ols: synthesis and topological relationship to oxide-bridged phenylmorphansYi Zhang, Yong Sok Lee, Richard B Rothman, et al.
Pageof 54

Showing results (351-360 of 532) with videos related to

Sort By:
Pageof 54
Peptides|January 1, 1993
Phenylpiperidine opioid antagonists that promote weight loss in rats have high affinity for the kappa 2B (enkephalin-sensitive) binding siteR B Rothman, H Xu, G U Char, et al.
Brain Research. Developmental Brain Research|February 1, 1989
Cross-linking of [125I]beta-endorphin to mu-opioid receptors during developmentS McLean, R B Rothman, D M Chuang, et al.
Journal of Substance Abuse Treatment|April 1, 2000
An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependenceR B Rothman, D A Gorelick, S J Heishman, et al.
Synapse (New York, N.Y.)|March 14, 2002
Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout miceRichard B Rothman, F Ivy Carroll, Marisela Morales, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2014
Alpha-ethyltryptamines as dual dopamine-serotonin releasersBruce E Blough, Antonio Landavazo, John S Partilla, et al.
Journal of Medicinal Chemistry|September 29, 2012
14-Alkoxy- and 14-acyloxypyridomorphinans: μ agonist/δ antagonist opioid analgesics with diminished tolerance and dependence side effectsSubramaniam Ananthan, Surendra K Saini, Christina M Dersch, et al.
Peptides|November 1, 1992
Probing the opioid receptor complex with (+)-trans-SUPERFIT. II. Evidence that mu ligands are noncompetitive inhibitors of the delta cx opioid peptide binding siteR B Rothman, A Mahboubi, V Bykov, et al.
Journal of Medicinal Chemistry|January 21, 2011
Probes for narcotic receptor mediated phenomena. 41. Unusual inverse μ-agonists and potent μ-opioid antagonists by modification of the N-substituent in enantiomeric 5-(3-hydroxyphenyl)morphansKejun Cheng, Yong Sok Lee, Richard B Rothman, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2009
Design, synthesis, and characterization of 6beta-naltrexol analogs, and their selectivity for in vitro opioid receptor subtypesAndrea L Pelotte, Ryan M Smith, Mario Ayestas, et al.
Journal of Medicinal Chemistry|July 25, 2009
Probes for narcotic receptor mediated phenomena. 39. Enantiomeric N-substituted benzofuro[2,3-c]pyridin-6-ols: synthesis and topological relationship to oxide-bridged phenylmorphansYi Zhang, Yong Sok Lee, Richard B Rothman, et al.
Pageof 54